| Abstrakt: |
Researchers at Nanjing Normal University in Jiangsu, China, have conducted a study on lung adenocarcinoma (LUAD) and the tumor stemness score (mRNAsi) as a potential molecular typing tool. The study found that mRNAsi is correlated with the prognosis and disease severity of LUAD patients, allowing for the identification of two molecular subtypes with different prognoses. The research suggests that these findings could have important clinical implications for monitoring and treating LUAD patients effectively. [Extracted from the article] |
